Alterity Therapeutics (ATHE) Other Working Capital Changes (2015 - 2020)
Alterity Therapeutics' quarterly Other Working Capital Changes came in at $35152.2 in Q2 2020, up 113.74% year-on-year from $16446.0 in Q3 2019, and up 115.98% quarter-over-quarter from -$220011.4 in Q4 2019.
Alterity Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at $35152.2 in Q2 2020.
- For the quarter ending Q2 2020, Other Working Capital Changes rose 113.74% year-over-year to $35152.2; the trailing twelve-month figure through Jun 2020 stood at -$551073.5 (down 72.53% YoY), and the FY2025 full-year result was $692540.8, up 315.38% from the prior year.
- Other Working Capital Changes for Q2 2020 stood at $35152.2, up from -$220011.4 in the prior quarter.
- The five-year high for Other Working Capital Changes was $46670.6 in Q4 2017, with the low at -$255773.2 in Q2 2019.
- Average Other Working Capital Changes over 5 years is -$77106.7, with a median of -$86350.9 recorded in 2016.
- Year-over-year, Other Working Capital Changes soared 146.53% in 2017 and tumbled 178033.96% in 2019.
- Tracing ATHE's Other Working Capital Changes over 5 years: stood at -$100293.2 in 2016, then soared by 146.53% to $46670.6 in 2017, then plunged by 336.64% to -$110441.0 in 2018, then tumbled by 99.21% to -$220011.4 in 2019, then jumped by 115.98% to $35152.2 in 2020.
- The last three Other Working Capital Changes figures came in at $35152.2 (Q2 2020), -$220011.4 (Q4 2019), and -$255773.2 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 35,152.17 |
| Jun 30, 2020 | 35,152.17 |
| Dec 31, 2019 | -220,011.42 |
| Dec 31, 2019 | -220,011.42 |
| Jun 30, 2019 | -255,773.25 |
| Jun 30, 2019 | -255,773.25 |
| Dec 31, 2018 | -110,441.04 |
| Dec 31, 2018 | -110,441.04 |
| Jun 30, 2018 | 143.75 |
| Jun 30, 2018 | 143.75 |
| Dec 31, 2017 | 46,670.64 |
| Dec 31, 2017 | 46,670.64 |
| Jun 30, 2017 | -3,056.67 |
| Jun 30, 2017 | -3,056.67 |
| Dec 31, 2016 | -100,293.18 |
| Dec 31, 2016 | -100,293.18 |
| Jun 30, 2016 | -86,350.91 |
| Jun 30, 2016 | -86,350.91 |
| Dec 31, 2015 | -33,251.12 |
| Dec 31, 2015 | -33,251.12 |